|
|
Volumn 35, Issue 12, 2013, Pages
|
|
Economic Burden of Adverse Events in Patients With Metastatic Renal Cell Carcinoma
|
|
Author keywords
Adverse events; Economic burden; Metastatic renal cell carcinoma; Targeted therapy
|
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
AMYLASE;
ASPARTATE AMINOTRANSFERASE;
BEVACIZUMAB;
BLEOMYCIN;
CARBOPLATIN;
CISPLATIN;
DOCETAXEL;
DOXORUBICIN;
GALLIUM NITRATE;
GEMCITABINE;
GLUCOSE;
HEMOGLOBIN;
IFOSFAMIDE;
METHOTREXATE;
PACLITAXEL;
PAZOPANIB;
PEMETREXED;
PHOSPHORUS;
SODIUM;
SORAFENIB;
SUNITINIB;
TRIACYLGLYCEROL LIPASE;
URIC ACID;
VINBLASTINE;
ABDOMINAL PAIN;
ABNORMAL LABORATORY RESULT;
ADULT;
ADVERSE DRUG REACTION;
AGED;
ARTICLE;
ASTHENIA;
BACKACHE;
CANCER CHEMOTHERAPY;
CHARLSON COMORBIDITY INDEX;
CHEMOTHERAPY INDUCED EMESIS;
CONTROLLED STUDY;
DIARRHEA;
DYSPNEA;
FATIGUE;
FEMALE;
GLUCOSE BLOOD LEVEL;
HAND FOOT SYNDROME;
HEALTH CARE COST;
HUMAN;
HYPERTENSION;
KIDNEY METASTASIS;
LEUKOCYTE;
LIMB PAIN;
LYMPHOCYTOPENIA;
MAJOR CLINICAL STUDY;
MALE;
MOLECULARLY TARGETED THERAPY;
NAUSEA;
NEUTROPENIA;
PROTEINURIA;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
RETROSPECTIVE STUDY;
SIDE EFFECT;
SODIUM BLOOD LEVEL;
THROMBOCYTOPENIA;
TRANSITIONAL CELL CARCINOMA;
ADVERSE EVENTS;
ECONOMIC BURDEN;
METASTATIC RENAL CELL CARCINOMA;
TARGETED THERAPY;
ADOLESCENT;
ADULT;
AGED;
AGED, 80 AND OVER;
ANGIOGENESIS INHIBITORS;
ANTINEOPLASTIC AGENTS;
CARCINOMA, RENAL CELL;
COST OF ILLNESS;
COST-BENEFIT ANALYSIS;
DATABASES, FACTUAL;
HEALTH CARE COSTS;
HUMANS;
INSURANCE CLAIM REVIEW;
KIDNEY NEOPLASMS;
MIDDLE AGED;
PROTEIN KINASE INHIBITORS;
RETROSPECTIVE STUDIES;
SEVERITY OF ILLNESS INDEX;
YOUNG ADULT;
|
|
EID: 84890314255
PISSN: 01492918
EISSN: 1879114X
Source Type: Journal
DOI: 10.1016/j.clinthera.2013.10.010 Document Type: Article |
|
Times cited : (17)
|
|
References (7)
|
